A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
UTI Healthcare Fund - Direct Plan
Regular
Direct
3 Year Absolute Returns
101.90% ↑
NAV (₹) on 06 Mar 2026
245.81
1 Day NAV Change
-0.32%
Risk Level
Very High Risk
Rating
-
UTI Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by UTI Asset Management Co. Ltd.. Launched on 01 Jan 2013, investors can start with a minimum SIP of ₹100 or ... Read more
NAV History
Fund Details
Min. SIP Amount
₹500
Inception Date
01 Jan 2013
Min. Lumpsum Amount
₹ 5,000
Fund Age
13 Yrs
AUM
₹ 1,055.01 Cr.
Benchmark
BSE Healthcare Total Return
Expense Ratio
1.29%
Scheme Type
Open Ended
Exit Load
1%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 1,055.01 Cr
Equity
97.34%
Debt
0.01%
Other Assets & Liabilities
2.66%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 71.71% |
| Hospitals & Medical Services | 22.50% |
| Current Assets | 2.66% |
| Chemicals - Speciality | 1.18% |
| Medical Research Services | 1.10% |
| Medical Equipment & Accessories | 0.85% |
| Short Term Deposits | 0.01% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| SUN PHARMACEUTICALS INDUSTRIES | 10.44% | ₹ 110.89 | Pharmaceuticals |
| CIPLA LTD. | 5.52% | ₹ 58.63 | Pharmaceuticals |
| DR REDDYS LABORATORIES LTD. | 4.66% | ₹ 49.55 | Pharmaceuticals |
| PROCTOR & GAMBLE HEALTH LTD | 4.34% | ₹ 46.15 | Pharmaceuticals |
| AJANTA PHARMA LTD. | 4.09% | ₹ 43.39 | Pharmaceuticals |
| GLENMARK PHARMACEUTICALS LTD. | 3.78% | ₹ 40.11 | Pharmaceuticals |
| APOLLO HOSPITALS ENTERPRISE LT | 3.65% | ₹ 38.72 | Hospitals & Medical Services |
| DIVIS LABORATORIES LTD. | 3.49% | ₹ 37.03 | Pharmaceuticals |
| FORTIS HEALTHCARE LTD. | 3.09% | ₹ 32.84 | Hospitals & Medical Services |
| ERIS LIFESCIENCES LTD | 3.04% | ₹ 32.34 | Pharmaceuticals |
| JUPITER LIFE LINE HOSPITALS LTD | 2.95% | ₹ 31.35 | Hospitals & Medical Services |
| KRISHNA INSTITUTE OF MEDI SCIE | 2.77% | ₹ 29.45 | Hospitals & Medical Services |
| AUROBINDO PHARMA LTD. | 2.70% | ₹ 28.70 | Pharmaceuticals |
| GLAND PHARMA LTD. | 2.69% | ₹ 28.59 | Pharmaceuticals |
| MAX HEALTHCARE INSTITUTE LTD | 2.67% | ₹ 28.35 | Hospitals & Medical Services |
| NET CURRENT ASSETS | 2.66% | ₹ 28.25 | Others |
| COHANCE LIFESCIENCES LIMITED | 2.65% | ₹ 28.13 | Pharmaceuticals |
| LUPIN LTD. | 2.58% | ₹ 27.41 | Pharmaceuticals |
| CAPLIN POINT LABORATORIES LTD | 2.53% | ₹ 26.83 | Pharmaceuticals |
| IPCA LABORATORIES LTD. | 2.06% | ₹ 21.89 | Pharmaceuticals |
| ASTER DM HEALTHCARE LTD | 2.03% | ₹ 21.57 | Hospitals & Medical Services |
| ALKEM LABORATORIES LTD | 1.92% | ₹ 20.39 | Pharmaceuticals |
| ZYDUS LIFESCIENCES LTD | 1.91% | ₹ 20.26 | Pharmaceuticals |
| GLOBAL HEALTH LTD. | 1.73% | ₹ 18.39 | Hospitals & Medical Services |
| PFIZER LIMITED | 1.64% | ₹ 17.41 | Pharmaceuticals |
| MARKSANS PHARMA LTD. | 1.64% | ₹ 17.41 | Pharmaceuticals |
| METROPOLIS HEALTHCARE LTD | 1.58% | ₹ 16.80 | Hospitals & Medical Services |
| SEQUENT SCIENTIFIC LTD | 1.57% | ₹ 16.71 | Pharmaceuticals |
| WINDLAS BIOTEC LTD | 1.30% | ₹ 13.80 | Pharmaceuticals |
| TORRENT PHARMACEUTICALS LTD. | 1.28% | ₹ 13.60 | Pharmaceuticals |
| VIJAYA DIAGNOSTIC CENTRE LTD | 1.26% | ₹ 13.39 | Hospitals & Medical Services |
| SANOFI CONSUMER HEALTHCARE INDIA LTD | 1.18% | ₹ 12.54 | Chemicals - Speciality |
| SYNGENE INTERNATIONAL LTD. | 1.10% | ₹ 11.64 | Medical Research Services |
| ALEMBIC PHARMACEUTICALS | 1.06% | ₹ 11.31 | Pharmaceuticals |
| JUBILANT PHARMOVA LIMITED | 0.99% | ₹ 10.53 | Pharmaceuticals |
| AMI ORGANICS LTD | 0.99% | ₹ 10.50 | Pharmaceuticals |
| EMCURE PHARMACEUTICALS LTD | 0.88% | ₹ 9.31 | Pharmaceuticals |
| LAXMI DENTAL LIMITED | 0.85% | ₹ 9.04 | Medical Equipment & Accessories |
| RAINBOW CHILDRENS MEDICARE LTD | 0.77% | ₹ 8.14 | Hospitals & Medical Services |
| SAI LIFE SCIENCES LTD | 0.72% | ₹ 7.60 | Pharmaceuticals |
| ORCHID PHARMA LTD. | 0.71% | ₹ 7.54 | Pharmaceuticals |
| CONCORD BIOTECH LTD | 0.53% | ₹ 5.63 | Pharmaceuticals |
| CLEARING CORPORATION OF INDIA LTD. STD - MARGIN | 0.01% | ₹ 0.11 | Others |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 0.95% | 9.58% | 13.61% | 26.39% |
| Category returns | -1.19% | 8.91% | 8.66% | 24.75% |
Fund Objective
An open-ended fund which exclusively invests in the equities of the Pharma & Healthcare sector companies. This fund is one of the growth sector funds aiming to invest in companies engaged in ... Read more
AMC Details
Name
UTI Asset Management Co. Ltd.
Date of Incorporation
01 Feb 2003
CEO
Mr. Vetri Subramaniam
CIO
Mr Vetri Subramaniam
Type
Bank Sponsored
Address
UTI Towers,
Gn Block,
Bandra Kurla Complex,
Bandra (East), Mumbai, Maharashtra, India - 400051
Website
https://www.utimf.com
Email
Top Funds from Equity - Sectoral/Thematic
Top Funds from UTI Asset Management Co. Ltd.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
UTI Conservative Hybrid Fund - Direct Plan
Hybrid
Direct
|
₹74.54 | 6.41% | 32.69% | 55.75% | ₹1,681 | 1.26% |
Moderately High
|
|
UTI Conservative Hybrid Fund - Direct Plan
Hybrid
Direct
|
₹75.77 | 6.41% | 32.69% | 55.75% | ₹1,681 | 1.26% |
Moderately High
|
|
UTI Large Cap Fund - Direct Plan
Largecap
Direct
|
₹61.57 | 4.33% | 32.64% | 46.02% | ₹12,839 | 0.91% |
Very High
|
|
UTI Large Cap Fund - Direct Plan
Largecap
Direct
|
₹61.57 | 4.33% | 32.64% | 46.02% | ₹12,839 | 0.91% |
Very High
|
|
UTI Flexi Cap Fund - Direct Plan
Largecap
Direct
|
₹313.12 | 0.10% | 31.27% | 41.81% | ₹23,542 | 1.05% |
Very High
|
|
UTI Flexi Cap Fund - Direct Plan
Largecap
Direct
|
₹208.38 | 0.10% | 31.27% | 34.77% | ₹23,542 | 1.05% |
Very High
|
|
UTI Flexi Cap Fund - Direct Plan
Largecap
Direct
|
₹208.38 | 0.10% | 31.27% | 34.77% | ₹23,542 | 1.05% |
Very High
|
|
UTI Aggressive Hybrid Fund - Direct Plan
Hybrid
Direct
|
₹45.51 | 1.21% | 30.42% | 43.97% | ₹6,654 | 1.20% |
Very High
|
|
UTI Aggressive Hybrid Fund - Direct Plan
Hybrid
Direct
|
₹45.51 | 1.21% | 30.42% | 43.97% | ₹6,654 | 1.20% |
Very High
|
|
UTI Childrens Hybrid Fund - Direct Plan
Hybrid
Direct
|
₹40.79 | 5.58% | 30.34% | 50.30% | ₹4,437 | 1.60% |
High
|
FAQs
What is the current NAV of UTI Healthcare Fund - Direct Plan IDCW?
The current Net Asset Value (NAV) of UTI Healthcare Fund - Direct Plan IDCW is ₹245.81 as of 06 Mar 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of UTI Healthcare Fund - Direct Plan IDCW?
The Assets Under Management (AUM) of UTI Healthcare Fund - Direct Plan IDCW is ₹1,055.01 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of UTI Healthcare Fund - Direct Plan IDCW?
UTI Healthcare Fund - Direct Plan IDCW has delivered returns of 9.58% (1 Year), 26.39% (3 Year), 16.53% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of UTI Healthcare Fund - Direct Plan IDCW?
UTI Healthcare Fund - Direct Plan IDCW has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for UTI Healthcare Fund - Direct Plan IDCW?
The minimum lumpsum investment required for UTI Healthcare Fund - Direct Plan IDCW is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹500, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
NPS vs Mutual Funds: बुढ़ापे के लिए कहां लगाएं पैसा? जानिए एनपीएस और म्यूचुअल फंड में कौन बेहतर -
Budget 2026 Expectations: बदल जाएंगे म्यूचुअल फंड के ये नियम? हो सकते हैं बड़े ऐलान! AMFI ने रखी 27 मांगें -
Indian Market: अगले 10 साल में बदल जाएगा देश का इन्वेस्टमेंट मैप? म्यूचुअल फंड AUM में होगा बड़ा धमाका -
ELSS vs Index Mutual Funds: कहां मिलेगा मोटा रिटर्न! निवेशकों को कौन-सा चुनना चाहिए और क्यों? -
बच्चे का फ्यूचर प्लान कर रहे हैं? SSY, PPF या Mutual Fund...कौन देगा सबसे ज्यादा रिटर्न? -
म्यूचुअल फंड रूल्स पर SEBI की सख्ती से हिला कैपिटल मार्केट! HDFC AMC; Nuvama के शेयर धड़ाम -
Lump Sum Investment: 11 लाख रुपये के निवेश से बनेगा 9 करोड़ का फंड! -
Jio Blackrock NFO को निवेशकों से तगड़ा रिस्पांस! जुटाए 17800 करोड़ रुपए, 30 जून को लॉन्च किए थे 3 फंड्स -
New Rules: 1 जून से लागू होगा म्यूचुअल फंड स्कीम्स से जुड़ा ये नियम, फटाफट कर लें चेक -
JioBlackrock को SEBI से मिली हरी झंडी, म्यूचुअल फंड मार्केट में होगी एंट्री, सिड स्वामीनाथन होंगे MD & CEO
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+